Skip to main content
Signal8
Ford Robert B profile photo

Robert B. Ford

CIK: 0001612571

Transaction Breakdown

Open Market Buys (P)1 (6.7%)

High conviction signal

Open Market Sales (S)5 (33.3%)

Position reduction

Option Exercises (M)5 (33.3%)

Derivative conversions

Awards (A)2 (13.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (13.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ABBOTT LABORATORIES logo
ABT

ABBOTT LABORATORIES

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (15 total)

  • ABBOTT LABORATORIES logo
    ABT

    ABBOTT LABORATORIES

    Aug 25, 2026
    Exercise(M)
    Direct
    151.9K shares at avg. $44.40$6.7M
  • ABBOTT LABORATORIES logo
    ABT

    ABBOTT LABORATORIES

    Aug 25, 2026
    Sale(S)
    Direct
    180.3K shares at avg. $116.19$20.9M
  • ABBOTT LABORATORIES logo
    ABT

    ABBOTT LABORATORIES

    Aug 25, 2026
    Sale(S)
    Direct
    218.5K shares at avg. $115.57$25.3M
  • ABBOTT LABORATORIES logo
    ABT

    ABBOTT LABORATORIES

    Aug 25, 2026
    Exercise(M)
    Direct
    247K shares at avg. $59.94$14.8M
  • ABBOTT LABORATORIES logo
    ABT

    ABBOTT LABORATORIES

    Feb 27, 2026
    Tax Payment(F)
    Direct
    30.3K shares at avg. $116.26$3.5M
  • ABBOTT LABORATORIES logo
    ABT

    ABBOTT LABORATORIES

    Feb 24, 2026
    Award(A)
    Direct
    83.5K shares-
  • ABBOTT LABORATORIES logo
    ABT

    ABBOTT LABORATORIES

    Jan 23, 2026
    Purchase(P)
    Indirect
    18.8K shares at avg. $107.13$2.0M
  • ABBOTT LABORATORIES logo
    ABT

    ABBOTT LABORATORIES

    Feb 28, 2025
    Tax Payment(F)
    Direct
    31.7K shares at avg. $135.87$4.3M
  • ABBOTT LABORATORIES logo
    ABT

    ABBOTT LABORATORIES

    Feb 25, 2025
    Award(A)
    Direct
    64.9K shares-
  • ABBOTT LABORATORIES logo
    ABT

    ABBOTT LABORATORIES

    Feb 5, 2025
    Sale(S)
    Direct
    285.4K shares at avg. $131.17$37.4M
  • ABBOTT LABORATORIES logo
    ABT

    ABBOTT LABORATORIES

    Feb 5, 2025
    Exercise(M)
    Direct
    285.4K shares at avg. $38.40$11.0M
  • ABBOTT LABORATORIES logo
    ABT

    ABBOTT LABORATORIES

    Sep 12, 2024
    Exercise(M)
    Direct
    14.2K shares at avg. $48.90$696K
  • ABBOTT LABORATORIES logo
    ABT

    ABBOTT LABORATORIES

    Sep 12, 2024
    Sale(S)
    Direct
    80.3K shares at avg. $116.04$9.3M
  • ABBOTT LABORATORIES logo
    ABT

    ABBOTT LABORATORIES

    Sep 12, 2024
    Sale(S)
    Direct
    61.4K shares at avg. $116.90$7.2M
  • ABBOTT LABORATORIES logo
    ABT

    ABBOTT LABORATORIES

    Sep 12, 2024
    Exercise(M)
    Direct
    127.4K shares at avg. $47.00$6.0M

1-15 of 15

About Ford Robert B

Ford Robert B (SEC CIK 0001612571) files insider reports with the SEC as CHAIRMAN AND CEO of ABBOTT LABORATORIES (ABT).

Signal8 holds 8 ownership filings by Ford Robert B, all Form 4s, filed between Sep 13, 2024 and Aug 27, 2026. Those filings report 15 transactions, from Sep 12, 2024 to Aug 25, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ford Robert B's filings is in ABBOTT PARK, IL.

Recent filings by Ford Robert B

  • Aug 25, 2026: Option exercise of ABT shares (Form 4, code M).
  • Aug 25, 2026: Open-market sales of ABT shares (2 lines, Form 4, code S).
  • Aug 25, 2026: Option exercise of ABT shares (Form 4, code M).
  • Feb 27, 2026: Tax withholding of ABT shares (Form 4, code F).
  • Feb 24, 2026: Grant or award of ABT shares (Form 4, code A).

Other insiders filing for ABBOTT LABORATORIES (ABT)

How to read Form 4 transaction codes